BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2358848)

  • 1. Intra-arterial BCNU in the treatment of recurrent medulloblastoma.
    Watne K; Hager B; Hirschberg H
    J Neurooncol; 1990 Apr; 8(2):139-43. PubMed ID: 2358848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective intra-arterial chemotherapy with BCNU in recurrent malignant gliomas.
    Bradac GB; Soffietti R; Riva A; Stura G; Sales S; Schiffer D
    Neuroradiology; 1992; 34(1):73-6. PubMed ID: 1313161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy in recurrent medulloblastoma.
    Duffner PK; Cohen ME; Thomas PR; Sinks LF; Freeman AI
    Cancer; 1979 Jan; 43(1):41-5. PubMed ID: 761175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of recurrent brain tumors with intra-arterial cis-platinum and BCNU.
    Kapp JP; Vance R
    J Miss State Med Assoc; 1984 Jan; 25(1):1-6. PubMed ID: 6325705
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of recurrent esthesioneuroblastoma with combined intra-arterial chemotherapy. A case report.
    Watne K; Hager B
    J Neurooncol; 1987; 5(1):47-50. PubMed ID: 3598620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
    Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
    Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
    Kapp J; Vance R; Parker JL; Smith RR
    Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
    [No Abstract]   [Full Text] [Related]  

  • 8. The chemotherapy of brain tumors. Clinical experience with carmustine (BCNU) and vincristine.
    Fewer D; Wilson CB; Boldrey EB; Enot KJ; Powell MR
    JAMA; 1972 Oct; 222(5):549-52. PubMed ID: 4343318
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacokinetics of superselective intra-arterial and intravenous [11C]BCNU evaluated by PET.
    Tyler JL; Yamamoto YL; Diksic M; Théron J; Villemure JG; Worthington C; Evans AC; Feindel W
    J Nucl Med; 1986 Jun; 27(6):775-80. PubMed ID: 3486962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Superselective intracerebral chemotherapy of malignant tumours with BCNU. Neuroradiological considerations.
    Théron J; Villemure JG; Worthington C; Tyler JL
    Neuroradiology; 1986; 28(2):118-25. PubMed ID: 3703233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
    Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
    J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intra-arterial BCNU in the treatment of metastatic brain tumors.
    Cascino TL; Byrne TN; Deck MD; Posner JB
    J Neurooncol; 1983; 1(3):211-8. PubMed ID: 6678970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraarterial 1,3-bis(2-chloroethyl)-1-nitrosourea chemotherapy for the treatment of malignant gliomas of the brain: a preliminary report.
    Safdari H; Mompeon B; Dubois JB; Gros C
    Surg Neurol; 1985 Nov; 24(5):490-7. PubMed ID: 4049223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-arterial BCNU chemotherapy for the treatment of malignant gliomas of the central nervous system: a preliminary report.
    Greenberg HS; Ensminger WD; Seeger JF; Kindt GW; Chandler F; Doan K; Dakhil SR
    Cancer Treat Rep; 1981; 65(9-10):803-10. PubMed ID: 7023671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
    Buckner JC; Brown LD; Kugler JW; Cascino TL; Krook JE; Mailliard JA; Kardinal CG; Tschetter LK; O'Fallon JR; Scheithauer BW
    J Neurosurg; 1995 Mar; 82(3):430-5. PubMed ID: 7861221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective study of the value of chemotherapy as adjuvant therapy to surgery and radiotherapy in grade 3 and 4 gliomas.
    Gundersen S; Lote K; Watne K
    Eur J Cancer; 1998 Sep; 34(10):1565-9. PubMed ID: 9893629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rationale and methodology for intra-arterial chemotherapy with BCNU as treatment for glioblastoma.
    Hochberg FH; Pruitt AA; Beck DO; DeBrun G; Davis K
    J Neurosurg; 1985 Dec; 63(6):876-80. PubMed ID: 2997415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of vincristine and cyclophosphamide in the therapy of recurrent medulloblastoma.
    Friedman HS; Mahaley MS; Schold SC; Vick NA; Falletta JM; Bullard DE; D'Souza BJ; Khandekar JD; Lew S; Oakes WJ
    Neurosurgery; 1986 Mar; 18(3):335-40. PubMed ID: 3703192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma. A case report.
    Bremer AM; Nguyen TQ; Balsys R
    J Neurooncol; 1984; 2(1):47-51. PubMed ID: 6470759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCNU as second line therapy for recurrent high-grade glioma previously treated with Temozolomide.
    Rosenthal MA; Ashley DL; Cher L
    J Clin Neurosci; 2004 May; 11(4):374-5. PubMed ID: 15080950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.